Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

The prevalence of hepatitis B virus markers in a cohort of students in Bangui, Central African Republic.

Komas NP, Baï-Sepou S, Manirakiza A, Léal J, Béré A, Le Faou A.

BMC Infect Dis. 2010 Jul 29;10:226. doi: 10.1186/1471-2334-10-226.

2.

Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.

Melo LV, da Silva MA, Calçada Cde O, Cavalcante SR, Souto FJ.

Vaccine. 2011 Jul 18;29(32):5290-3. doi: 10.1016/j.vaccine.2011.05.011. Epub 2011 May 23.

PMID:
21605613
3.

Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.

Rey-Cuille MA, Njouom R, Bekondi C, Seck A, Gody C, Bata P, Garin B, Maylin S, Chartier L, Simon F, Vray M.

Pediatr Infect Dis J. 2013 Oct;32(10):1110-5. doi: 10.1097/INF.0b013e31829be401.

PMID:
23694839
4.

High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic.

Pawlotsky JM, Bélec L, Grésenguet G, Deforges L, Bouvier M, Duval J, Dhumeaux D.

J Med Virol. 1995 Jul;46(3):269-72.

PMID:
7561802
5.

Seroprevalence of hepatitis B virus markers in individuals for physical examination in West China Hospital, China.

Wang YB, Chen EQ, Cui YL, Zeng L, Wang YJ, Tang H.

Eur Rev Med Pharmacol Sci. 2011 Jun;15(6):592-6.

PMID:
21796864
6.

The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.

Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ.

Vaccine. 2001 Jul 16;19(28-29):3919-26.

PMID:
11427266
7.

Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.

Freitas SZ, Soares CC, Tanaka TS, Lindenberg AS, Teles SA, Torres MS, Mello FC, Mendes-Corrêa MC, Savassi-Ribas F, Motta-Castro AR.

Braz J Infect Dis. 2014 Sep-Oct;18(5):473-80. doi: 10.1016/j.bjid.2014.01.005. Epub 2014 Mar 22.

8.

Hepatitis B surface antibodies in medical students from a public university in Puebla, Mexico.

Cárdenas-Perea ME, Gómez-Conde E, Santos-López G, Pérez-Contreras I, Díaz-Orea MA, Gándara-Ramírez JL, Cruz Y López OR, Márquez-Domínguez L, Sosa-Jurado F.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1857-62. doi: 10.1080/21645515.2016.1151587. Epub 2016 May 12.

9.

Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China.

Zhang H, Li Q, Sun J, Wang C, Gu Q, Feng X, Du B, Wang W, Shi X, Zhang S, Li W, Jiang Y, Feng J, He S, Niu J.

Int J Med Sci. 2011;8(4):321-31. Epub 2011 May 20.

10.

Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.

Wang WL, Shu ZJ, Zhou LX, Zhao YR.

Arch Virol. 2012 May;157(5):901-5. doi: 10.1007/s00705-012-1251-9. Epub 2012 Feb 11.

PMID:
22327392
11.

Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.

Lai MW, Lin TY, Tsao KC, Huang CG, Hsiao MJ, Liang KH, Yeh CT.

Gastroenterology. 2012 Aug;143(2):400-7. doi: 10.1053/j.gastro.2012.05.002. Epub 2012 May 10.

PMID:
22580098
12.

Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.

Vargas JI, Jensen D, Sarmiento V, Peirano F, Acuña P, Fuster F, Soto S, Ahumada R, Huilcaman M, Bruna M, Jensen W, Fuster F.

J Med Virol. 2016 Apr;88(4):639-46. doi: 10.1002/jmv.24384. Epub 2015 Sep 28.

PMID:
26381185
13.

Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.

Braga WS, Castilho Mda C, Borges FG, Martinho AC, Rodrigues IS, Azevedo EP, Scazufca M, Menezes PR.

Rev Soc Bras Med Trop. 2012 Feb;45(1):13-7.

14.
15.

Prevalence of hepatitis B virus (HBV) in Italian adolescents.

Di Ciommo V, Ferrario F, Spina G, La Spesa F, Rubino S.

Boll Ist Sieroter Milan. 1990 Jun;69(2):437-9.

PMID:
2152302
16.

Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil.

Oliveira MD, Martins RM, Matos MA, Ferreira RC, Dias MA, Carneiro MA, Junqueira AL, Teles SA.

Mem Inst Oswaldo Cruz. 2006 May;101(3):251-6.

17.

Hepatitis B virus markers in anti-HBc only positive individuals.

Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H.

J Med Virol. 2001 Jul;64(3):312-9.

PMID:
11424120
18.

Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study.

Liu J, Zhang S, Wang Q, Shen H, Zhang M, Zhang Y, Yan D, Liu M.

Lancet Infect Dis. 2016 Jan;16(1):80-86. doi: 10.1016/S1473-3099(15)00218-2. Epub 2015 Aug 9.

PMID:
26268687
19.

Hepatitis B virus prevalence and vaccination response in health care workers and students at the Federal University of Bahia, Brazil.

Carvalho P, Schinoni MI, Andrade J, Vasconcelos Rêgo MA, Marques P, Meyer R, Araújo A, Menezes T, Oliveira C, Macêdo RS, Macêdo LS, Leal JC, Matos B, Schaer R, Simones JM, Freire SM, Paraná R.

Ann Hepatol. 2012 May-Jun;11(3):330-7.

20.

Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program.

Chen CC, Yen CH, Wu WY, Hu SW, Chen SC, Bell WR, Lee MC.

Chin Med J (Engl). 2007 Jul 5;120(13):1155-8.

PMID:
17637244

Supplemental Content

Support Center